Works matching DE "ROMIPLOSTIM"

Results: 59

Efficacy of romiplostim in the treatment of ITP in children: a meta-analysis.

Published in:

European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 18, p. 6162

By:

LI, H.;
YANG, H.;
LIU, W. J.

Publication type:

Article

The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation.

Published in:

Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 837, doi. 10.3390/biom13050837

By:

Yamaguchi, Masaru;
Kashiwakura, Ikuo

Publication type:

Article

Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.

Published in:

Patient Preference & Adherence, 2020, v. 14, p. 1237, doi. 10.2147/PPA.S192481

By:

Gilbert, Megan M;
Grimes, Amanda B;
Kim, Taylor Olmsted;
Despotovic, Jenny M

Publication type:

Article

An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia.

Published in:

Expert Review of Clinical Immunology, 2022, v. 18, n. 8, p. 783, doi. 10.1080/1744666X.2022.2098119

By:

Song, Andrew B.;
Al‐Samkari, Hanny

Publication type:

Article

Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis.

Published in:

Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582686

By:

Meng, Fanqiao;
Chen, Xiuqiong;
Yu, Shunjie;
Ren, Xiaotong;
Liu, Zhaoyun;
Fu, Rong;
Li, Lijuan

Publication type:

Article

Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy.

Published in:

Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.019

By:

Napolitano, Mariasanta;
Vianelli, Nicola;
Ghiotto, Lisanna;
Cantoni, Silvia;
Carli, Giuseppe;
Carpenedo, Monica;
Carrai, Valentina;
Consoli, Ugo;
Giuffrida, Gaetano;
Lucchini, Elisa;
Rossi, Elena;
Santoro, Cristina;
Rodeghiero, Francesco

Publication type:

Article

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists.

Published in:

Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.021

By:

Carpenedo, Monica;
Zappaterra, Arianna;
Ferrari, Beatrice;
Cotilli, Giulia

Publication type:

Article

Pharmacokinetics, Safety, and Pharmacodynamics of Romiplostim in Chinese Subjects With Immune Thrombocytopenia: A Phase I/II Trial.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 3, p. 379, doi. 10.1002/cpdd.1059

By:

Qi, Junyuan;
Zheng, Li;
Hu, Bei;
Zhou, Hu;
He, Qing;
Liu, Hong;
Kawai, Hironori;
Yang, Renchi

Publication type:

Article

Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations.

Published in:

2022

By:

Ibrahim, Abukhiran;
Sharathkumar, Anjali;
McLaughlin, Heather;
Claassen, David;
Bhagavathi, Sharathkumar

Publication type:

Case Study

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.

Published in:

2015

By:

Carpenedo, Monica;
Cantoni, Silvia;
Coccini, Veronica;
Fedele, Marilena;
Morra, Enrica;
Pogliani, Enrico Maria

Publication type:

Case Study

Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 10, p. 2499, doi. 10.1080/10428194.2022.2074992

By:

Sakaki, Ayaka;
Hosoi, Hiroki;
Kosako, Hideki;
Furuya, Yoshiaki;
Iwamoto, Ryuta;
Hiroi, Takayuki;
Murata, Shogo;
Mushino, Toshiki;
Murata, Shin-Ichi;
Sonoki, Takashi

Publication type:

Article

Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies.

Published in:

Platelets, 2022, v. 33, n. 8, p. 1312, doi. 10.1080/09537104.2022.2117293

By:

Cheloff, Abraham Z.;
Al‐Samkari, Hanny

Publication type:

Article

Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.

Published in:

Platelets, 2020, v. 31, n. 3, p. 403, doi. 10.1080/09537104.2019.1615613

By:

Rosa María, Rodriguez Nuñez;
Laura, Rubio Lacambra;
Ángeles, Palomo Bravo;
Laura, Langenhorst Baniandres

Publication type:

Article

Developmental differences between newborn and adult mice in response to romiplostim.

Published in:

Platelets, 2018, v. 29, n. 4, p. 365, doi. 10.1080/09537104.2017.1316481

By:

Sparger, Katherine A.;
Ramsey, Haley;
Lorenz, Viola;
Liu, Zhi-Jian;
Feldman, Henry A.;
Li, Nan;
Laforest, Tahirih;
Sola-Visner, Martha C.

Publication type:

Article

Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.

Published in:

Platelets, 2012, v. 23, n. 4, p. 264, doi. 10.3109/09537104.2011.619601

By:

Mokhtar, Galila M.;
Tantawy, Azza A. G.;
El Sherif, Nayera H. K.

Publication type:

Article

An Analysis of the Serum Metabolomic Profile for the Radiomitigative Effect of the Thrombopoietin Receptor Agonist Romiplostim in Lethally Whole-Body-Irradiated Mice.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/metabo12020161

By:

Sato, Yoshiaki;
Yamaguchi, Masaru;
Kashiwakura, Ikuo

Publication type:

Article

Controlling for Differential Regression-To-The-Mean via Propensity Scores: A Simulation Study.

Published in:

Clinical Epidemiology, 2023, v. 15, p. 661, doi. 10.2147/CLEP.S406552

By:

Latour, Chase D;
McGrath, Leah J;
Clouser, Mary;
Nielson, Carrie;
Yu, Ying;
Balasubramanian, Akhila;
Breskin, Alexander;
Brookhart, M Alan

Publication type:

Article

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.

Published in:

British Journal of Haematology, 2019, v. 185, n. 3, p. 503, doi. 10.1111/bjh.15803

By:

Kuter, David J.;
Newland, Adrian;
Chong, Beng H.;
Rodeghiero, Francesco;
Romero, Monica T.;
Pabinger, Ingrid;
Chen, Yuqi;
Wang, Kejia;
Mehta, Bhakti;
Eisen, Melissa

Publication type:

Article

Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.

Published in:

2018

By:

Al‐Samkari, Hanny;
Kuter, David J.

Publication type:

Case Study

Romiplostim for the management of perioperative thrombocytopenia.

Published in:

British Journal of Haematology, 2018, v. 182, n. 1, p. 106, doi. 10.1111/bjh.15280

By:

Al‐Samkari, Hanny;
Marshall, Ariela L.;
Goodarzi, Katayoon;
Kuter, David J.

Publication type:

Article

The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.

Published in:

British Journal of Haematology, 2017, v. 176, n. 6, p. 991, doi. 10.1111/bjh.14024

By:

Gill, Harinder;
Leung, Garret M. K.;
Lopes, David;
Kwong, Yok ‐ Lam

Publication type:

Article

Use of eltrombopag after romiplostim in primary immune thrombocytopenia.

Published in:

British Journal of Haematology, 2015, v. 169, n. 1, p. 111, doi. 10.1111/bjh.13266

By:

González‐Porras, José Ramón;
Mingot‐Castellano, María Eva;
Andrade, Marcio M.;
Alonso, Rafael;
Caparrós, Isabel;
Arratibel, María Carmen;
Fernández‐Fuertes, Fernando;
Cortti, Maria José;
Pascual, Cristina;
Sánchez‐González, Blanca;
Bernat, Silvia;
Fuertes‐Palacio, Miguel Angel;
Vázquez‐Paganini, Juan Andrés;
Olivera, Pavel E.;
Alvarez‐Román, María Teresa;
Jarque, Isidro;
Cortés, Montserrat;
Martínez‐Robles, Violeta;
Díaz‐Gálvez, Francisco Javier;
Calbacho, María

Publication type:

Article

Romiplostim for management of chemotherapy-induced thrombocytopenia.

Published in:

Supportive Care in Cancer, 2014, v. 22, n. 5, p. 1217, doi. 10.1007/s00520-013-2074-2

By:

Parameswaran, R.;
Lunning, M.;
Mantha, S.;
Devlin, S.;
Hamilton, A.;
Schwartz, G.;
Soff, G.

Publication type:

Article

Protein Expression and Purification of Romiplostim and Analysis of Its Secretory Production Using an In Silico Investigated Signal Peptide in E. Coli.

Published in:

Reports of Biochemistry & Molecular Biology, 2023, v. 12, n. 1, p. 27

By:

Hashemzaei, Masoud;
Negahdaripour, Manica;
Heidari, Reza;
Ghoshoon, Mohammad Bagher

Publication type:

Article

Proteomic changes by radio-mitigative thrombopoietin receptor agonist romiplostim in the blood of mice exposed to lethal total-body irradiation.

Published in:

International Journal of Radiation Biology, 2020, v. 96, n. 9, p. 1125, doi. 10.1080/09553002.2020.1787546

By:

Nishida, Teruki;
Yamaguchi, Masaru;
Tatara, Yota;
Kashiwakura, Ikuo

Publication type:

Article

Romiplostim (NplateVR) as an effective radiation countermeasure to improve survival and platelet recovery in mice.

Published in:

International Journal of Radiation Biology, 2020, v. 96, n. 1, p. 145, doi. 10.1080/09553002.2019.1605465

By:

Bunin, Deborah I.;
Bakke, James;
Green, Carol E.;
Javitz, Harold S.;
Fielden, Mark;
Chang, Polly Y.

Publication type:

Article

Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data.

Published in:

Current Medical Research & Opinion, 2024, v. 40, n. 5, p. 781, doi. 10.1080/03007995.2024.2328653

By:

Liang, Yi;
Rascati, Karen;
Barner, Jamie C.;
Lawson, Kenneth A.;
Nair, Radhika

Publication type:

Article

Missing Cells - A Rare Case of Persisting Thrombocytopenia in Pregnancy With Dengue and Role of Romiplostim in These Cases.

Published in:

2023

By:

Sinha, Ruchita;
Datta, Mamta Rath;
Singh, Vinita

Publication type:

Case Study

Romiplostim in the management of the thrombocytopenic surgical patient.

Published in:

2015

By:

Marshall, Ariela L.;
Goodarzi, Katayoon;
Kuter, David J.

Publication type:

journal article

Sustained Remission Off-Treatment (SROT) of TPO-RAs: The Burgos Ten-Step Eltrombopag Tapering Scheme.

Published in:

Medicina (1010660X), 2023, v. 59, n. 4, p. 659, doi. 10.3390/medicina59040659

By:

González-López, Tomás José;
Provan, Drew

Publication type:

Article

Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination.

Published in:

2021

By:

Nutalapati, Snigdha;
Gupta, Garima;
Hildebrandt, Gerhard C.

Publication type:

Case Study

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia.

Published in:

ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 715, doi. 10.2147/CEOR.S177338

By:

Tremblay, Gabriel;
Dolph, Mike;
Bhor, Menaka;
Said, Qayyim;
Roy, Anuja;
Elliott, Brian;
Briggs, Andrew

Publication type:

Article

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia.

Published in:

ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 705, doi. 10.2147/CEOR.S177324

By:

Tremblay, Gabriel;
Dolph, Mike;
Bhor, Menaka;
Said, Qayyim;
Elliott, Brian;
Briggs, Andrew

Publication type:

Article

Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia.

Published in:

Pharmaceutics, 2023, v. 15, n. 2, p. 344, doi. 10.3390/pharmaceutics15020344

By:

Fan, Xiaoqing;
Krzyzanski, Wojciech;
Liu, Dongyang;
Wong, Raymond S. M.;
Yan, Xiaoyu

Publication type:

Article

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice.

Published in:

Pharmaceutics, 2022, v. 14, n. 3, p. 514, doi. 10.3390/pharmaceutics14030514

By:

Nakai, Kensaku;
Misugi, Takuya;
Kitada, Kohei;
Kurihara, Yasushi;
Tahara, Mie;
Hamuro, Akihiro;
Nakano, Akemi;
Koyama, Masayasu;
Kira, Yukimi;
Tachibana, Daisuke

Publication type:

Article

Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients.

Published in:

Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1215, doi. 10.3390/ph16091215

By:

Hamed, Eman Mostafa;
Ibrahim, Ahmed R. N.;
Meabed, Mohamed Hussein;
Khalaf, Ahmed M.;
El Demerdash, Doaa Mohamed;
Elgendy, Marwa O.;
Saeed, Haitham;
Salem, Heba F.;
Rabea, Hoda

Publication type:

Article

The Outcomes and Adverse Drug Patterns of Immunomodulators and Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia Egyptian Patients with Hemorrhage Comorbidity.

Published in:

Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 868, doi. 10.3390/ph16060868

By:

Hamed, Eman Mostafa;
Ibrahim, Ahmed R. N.;
Meabed, Mohamed Hussein;
Khalaf, Ahmed M.;
El Demerdash, Doaa Mohamed;
Elgendy, Marwa O.;
Saeed, Haitham;
Salem, Heba F.;
Rabea, Hoda

Publication type:

Article

Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.

Published in:

European Journal of Haematology, 2013, v. 91, n. 5, p. 423, doi. 10.1111/ejh.12181

By:

Rodeghiero, Francesco;
Stasi, Roberto;
Giagounidis, Aristoteles;
Viallard, Jean‐François;
Godeau, Bertrand;
Pabinger, Ingrid;
Cines, Douglas;
Liebman, Howard;
Wang, Xuena;
Woodard, Paul

Publication type:

Article

Review article: THE ROLE OF ELTROMBOPAG AND ROMIPLOSTIM AS THE THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) IN TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP): WHAT IS TPO-RA, WHEN TPO-RA IS USED AND HOW TO TAKE TPO-RA?

Published in:

Folia Medica Indonesiana, 2015, v. 51, n. 3, p. 203

By:

Susanto, Jefri Pratama

Publication type:

Article

The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia - a single center experience.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2022, v. 79, n. 10, p. 958, doi. 10.2298/VSP210721090V

By:

Virijević, Marijana;
Mitrović, Mirjana;
Pantić, Nikola;
Pravdić, Zlatko;
Sabljić, Nikica;
Suvajdžić-Vuković, Nada

Publication type:

Article

Avatrombopag v léčbě trombocytopenií – lékový profi l přípravku Doptelet.

Published in:: Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 4, p. 267
Publication type:: Article

Doporučení České hematologické společnosti pro diagnostiku a léčbu imunitní trombocytopenie dospělých.

Published in:

Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2023, v. 29, n. 1, p. 68

By:

Kozák, T.;
Čermák, J.;
Černá, O.;
Červinek, L.;
Gumulec, J.;
Hluší, A.;
Konířová, E.;
Košťál, M.;
Maaloufová, J.;
Pospíšilová, D.;
Smíšek, P.

Publication type:

Article

Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Controlled Study.

Published in:

Acta Haematologica, 2023, v. 146, n. 3, p. 173, doi. 10.1159/000528642

By:

Liu, Yin;
Zhang, Han-Xi;
Su, Juan;
Geng, Qing-Chao;
Lin, Xin;
Feng, Chen-Xi

Publication type:

Article

Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany.

Published in:

Acta Haematologica, 2022, v. 145, n. 4, p. 394, doi. 10.1159/000521689

By:

Reiser, Marcel;
Josten, Klaus M.;
Dietzfelbinger, Hermann;
Seesaghur, Anouchka;
Schill, Markus;
Hippenmeyer, Jane;
Welslau, Manfred

Publication type:

Article

Romiplostim for treatment of thrombocytopenia in dogs: A retrospective assessment and clinical outcomes.

Published in:

Journal of Veterinary Internal Medicine, 2024, v. 38, n. 4, p. 2158, doi. 10.1111/jvim.17131

By:

Ryu, Min‐Ok;
Kim, Jin‐Kyung;
An, Ju‐Hyun;
Seo, Kyoung‐Won;
Oh, Ye‐In;
Youn, Hwa‐Young

Publication type:

Article

Uso de romiplostim en trombocitopenia inmunitaria: experiencia en Cuenca (Ecuador).

Published in:

Biomédica: Revista del Instituto Nacional de Salud, 2024, v. 44, p. 198, doi. 10.7705/biomedica.7059

By:

Chiang-Wong, Héctor;
González-Saldaña, Patricio

Publication type:

Article

Treatment of 5 dogs with immunemediated thrombocytopenia using Romiplostim.

Published in:

BMC Veterinary Research, 2016, v. 12, p. 1, doi. 10.1186/s12917-016-0718-4

By:

Kohn, Barbara;
Bal, Gürkan;
Chirek, Aleksandra;
Rehbein, Sina;
Salama, Abdulgabar

Publication type:

Article

Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.

Published in:

Annals of Hematology, 2023, v. 102, n. 10, p. 2895, doi. 10.1007/s00277-023-05410-3

By:

Kurita, Naoki;
Nishikii, Hidekazu;
Maruyama, Yumiko;
Suehara, Yasuhito;
Hattori, Keiichiro;
Sakamoto, Tatsuhiro;
Kato, Takayasu;
Yokoyama, Yasuhisa;
Obara, Naoshi;
Maruo, Kazushi;
Ohigashi, Tomohiro;
Yamaguchi, Hitomi;
Iwamoto, Toshiro;
Minohara, Hideto;
Matsuoka, Ryota;
Hashimoto, Koichi;
Sakata-Yanagimoto, Mamiko;
Chiba, Shigeru

Publication type:

Article

Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.

Published in:

Annals of Hematology, 2021, v. 100, n. 9, p. 2143, doi. 10.1007/s00277-021-04590-0

By:

Grainger, John D.;
Kühne, Thomas;
Hippenmeyer, Jane;
Cooper, Nichola

Publication type:

Article

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia.

Published in:

Research Results in Pharmacology, 2023, v. 9, n. 1, p. 49, doi. 10.18413/rrpharmacology.9.10011

By:

Levchenkova, Olga S.;
Vorobieva, Viktoriya V.;
Novikov, Vasiliy E.;
Legonkova, Tatiana I.;
Volkova, Elena N.

Publication type:

Article